Veritas Capital to buy Verisk Health for $820 mln
Veritas Capital has agreed to buy the healthcare service business of Verisk Analytics Inc for $820 million. Waltham, Massachusetts-based Verisk Health provides data services, analytics, and advanced technologies that aim to inform smarter business decisions and reduce risk. The purchase price consists of $720 million of cash and a $100 million long-term subordinated promissory note. Morgan Stanley and SunTrust Robinson Humphrey provided financial advice to Verisk Analytics while McCarter & English LLP and Davis Polk & Wardwell was their legal advisor. Skadden, Arps, Slate, Meagher & Flom is acting as legal advisor to Veritas.
26 April 2016•4 mins read
